查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1206701

消化性潰瘍治療市場:按產品類型(質子泵抑製劑,鉀競爭性酸阻滯劑(P-CAB),抗酸劑,H2拮抗劑,抗生素,潰瘍保護),潰瘍類型,分銷渠道,地區,2023-2028年

Peptic Ulcer Drugs Market by Product (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker ), Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type, Distribution Channel, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022年全球消化性潰瘍藥物市場規模將達到46.3億美元。展望未來，IMARC Group 預測到 2028 年將達到 59.6 億美元，2023 年至 2028 年的增長率 (CAGR) 為 3.03%。消化性潰瘍病的患病率上升，尤其是在老年人中，以及消費者對各種藥物治療的偏好超過侵入性外科手術是推動市場的關鍵因素。

消化性潰瘍（十二指腸潰瘍）是一種開放性潰瘍，逐漸發展並導致胃、小腸和食道下段的粘膜出現缺陷。它通常由炎症、放射治療、頻繁口服或註射阿司匹林以及服用消炎藥引起。如果不及時治療，消化性潰瘍會導致中上半身劇烈疼痛、體重減輕、內出血、嚴重出血等，甚至可能需要住院治療。現在可以使用多種藥物治療，包括質子泵抑製劑 (PPI)、H2 拮抗劑、抗生素、鉀競爭性酸阻滯劑 (P-CAB)、抗酸劑和潰瘍保護劑。這些藥物可減輕疼痛、延長癒合時間、減少胃酸分泌、幫助抵抗細菌感染並保護胃免受消化液的影響。因此，消化性潰瘍藥物被醫療保健專業人員廣泛用於治療胃炎、胃食管反流病 (GERD) 和十二指腸潰瘍。

消化性潰瘍藥物市場趨勢

  • 消化性潰瘍患病率的增加，尤其是在老年人中，是推動市場增長的關鍵因素之一。此外，由於不健康的生活方式和胃癌的增加，患消化性潰瘍的人數也在增加。此外，由於不健康的生活方式和胃癌的增加，消化性潰瘍患者的數量正在增加，消費者對各種消化性潰瘍藥物而非侵入性外科手術的偏好正在推動市場增長。相應地，與手術相比，甾體類抗炎藥的侵入性更小，價格也更便宜，恢復更快，出血更少。此外，消化性潰瘍藥物的持續批准以及政府對製藥公司的幾項藥物處方投資正在支持市場的增長。此外，繼續實施臨床試驗以創造新藥以克服並發症以及市場上現有藥物的低療效也產生了影響。此外，消費者越來越意識到具有成本效益的消化性潰瘍藥物的好處以及跨多個分銷渠道的便捷可用性正在對市場增長產生積極影響。此外，用於執行診斷和法醫操作的基於人工智能 (AI) 的病理測試技術的出現也是市場增長的驅動因素。除其他因素外，為提高產品功效而進行的廣泛研發 (R&D) 活動以及對開發治療消化性潰瘍的非處方 (OTC) 藥物的投資增加對市場增長產生了積極影響。有人提到它有影響在

主要市場細分

  • IMARC Group 分析了全球消化性潰瘍藥物市場每個細分市場的主要趨勢，並預測了 2023-2028 年在全球、區域和國家層面的情況。該報告根據產品類型、潰瘍類型和分銷渠道對市場進行分類。

產品類型見解

  • 質子泵抑製劑
  • 競爭性酸阻滯劑 (P-CAB)
  • 抗酸劑
  • H2拮抗劑
  • 抗生素
  • 潰瘍保護劑
  • 該報告還根據消化性潰瘍藥物市場的產品類型提供了詳細的細分和分析。這些包括質子泵抑製劑、鉀競爭性酸阻滯劑 (P-CAB)、抗酸劑、H2 拮抗劑、抗生素、潰瘍保護劑等。根據這份報告，抗生素佔最大部分。

深入了解潰瘍類型

  • 胃潰瘍
  • 十二指腸潰瘍
  • 其他
  • 報告還提供了基於潰瘍類型的消化性潰瘍藥物市場的詳細細分和分析。這包括胃潰瘍、十二指腸潰瘍等。據報導，十二指腸潰瘍佔據了最大的市場份額。

分銷渠道洞察力

  • 醫院藥房
  • 零售藥店
  • 網上藥店
  • 該報告還根據消化性潰瘍藥物市場的分銷渠道提供了詳細的細分和分析。這包括醫院、零售店和在線藥店。根據這份報告，醫院藥房佔最大部分。

區域見解

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲
  • 北美（美國、加拿大）、亞太（中國、日本、印度、韓國、澳大利亞、印度尼西亞等）、歐洲（德國、法國、英國、意大利、西班牙、俄羅斯等）、拉丁美洲（巴西） 、墨西哥、其他），以及對包括中東和非洲在內的所有主要區域市場的綜合分析。另外，北美是消化性潰瘍藥物的最大市場。推動北美消化性潰瘍藥物市場的因素包括消化性潰瘍患病率的增加，尤其是在老年人口中，消費者對各種消化性潰瘍藥物的偏好超過侵入性手術，健康這些包括推動對非處方藥（OTC）的需求護理部門的藥物。

本報告回答的關鍵問題

  • 迄今為止，全球消化性潰瘍藥物市場表現如何，未來幾年會是什麼樣子？
  • 全球消化性潰瘍治療市場的驅動因素、制約因素和機遇是什麼？
  • 主要的區域市場是什麼？
  • 哪個國家的消化性潰瘍藥物市場最具吸引力？
  • 基於產品類型的市場細分是什麼？
  • 基於潰瘍類型的市場細分是什麼？
  • 銷售渠道的市場細分是什麼？
  • 全球消化性潰瘍藥物市場競爭格局如何？
  • 誰是全球消化性潰瘍治療市場的主要參與者/公司？

目錄

第一章 前言

第二章調查方法和範圍

  • 調查目的
  • 利益相關者
  • 數據源
    • 主要信息
    • 次要信息
  • 市場估計
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章執行摘要

第 4 章 簡介

  • 概述
  • 主要行業趨勢

5 消化性潰瘍藥物的全球市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章按產品類型劃分的市場細分

  • 質子泵抑製劑
    • 市場趨勢
    • 市場預測
  • 競爭性酸阻滯劑 (P-CAB)
    • 市場趨勢
    • 市場展望
  • 抗酸劑
    • 市場趨勢
    • 市場預測
  • H2拮抗劑
    • 市場趨勢
    • 市場預測
  • 抗生素
    • 市場趨勢
    • 市場預測
  • 潰瘍保護劑
    • 市場趨勢
    • 市場預測

7. 潰瘍類型的市場細分

  • 胃潰瘍
    • 市場趨勢
    • 市場展望
  • 十二指腸潰瘍
    • 市場趨勢
    • 市場展望
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章按分銷渠道劃分的市場細分

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥店
    • 市場趨勢
    • 市場預測
  • 網上藥店
    • 市場趨勢
    • 市場預測

第 9 章按地區劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東/非洲
    • 市場趨勢
    • 按國家劃分的市場細分
    • 市場預測

第 10 章加速器、約束和機會

  • 概述
  • 促進者
  • 抑製劑條件
  • 商機

第十一章價值鏈分析

第12章波特五力分析

  • 概述
  • 買方議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章價格分析

第十四章競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • Novitium Pharma LLC
    • Pfizer Inc.
    • PharmaKing Co. Ltd.
    • RedHill Biopharma Ltd
    • Viatris Inc.
    • Yuhan Corporation
    • Zydus Lifesciences Limited

本報告所列公司名稱僅為部分公司名稱，所有公司名稱均包含在本報告中。

Product Code: SR1323A173_Report

The global peptic ulcer drugs market size reached US$ 4.63 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.96 Billion by 2028, exhibiting a growth rate (CAGR) of 3.03% during 2023-2028. The increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various medications over invasive surgeries represent some of the key factors driving the market.

Peptic ulcers, or duodenal ulcers, are open sore that gradually develops and triggers defects in the lining of the stomach, small intestine, and lower esophagus. They are usually caused due to inflammation, radiation therapy, frequent oral and injectable administration of aspirins, and anti-inflammatory drugs. If peptic ulcers are left untreated, they might initiate severe pain in the mid- or upper-body parts, weight loss, internal bleeding, and severe blood loss, which require hospitalization. Currently, they can be treated with various drug types, including proton pump inhibitors (PPI), H2 antagonists, antibiotics, potassium-competitive acid blockers (P-CAB), antacids, and ulcer protectives. These medications reduce body aches, provide more time to heal, minimize acid secretion, offer resistance against bacterial infections, and protect the stomach from digestive juices. As a result, peptic ulcer drugs are extensively utilized by healthcare practitioners for the treatment of gastritis, gastroesophageal reflux disease (GERD), and duodenal ulcers.

Peptic Ulcer Drugs Market Trends:

  • The increasing prevalence of peptic ulcers, especially amongst the geriatric population, represents one of the key factors driving the market growth. Moreover, unhealthy lifestyle habits and rising instances of stomach cancer, is resulting in the growing number of individuals suffering from peptic ulcers. This, along with the shifting consumer inclination towards various peptic ulcer-curing drugs over invasive surgeries, which, in turn, is contributing to the market growth. In line with this, as compared to surgical procedures, several steroidal anti-inflammatory medications are minimally invasive, more affordable, and enable faster recovery while ensuring reduced blood loss. Additionally, the ongoing approvals of peptic ulcer drugs and several government investments in pharmaceutical companies for the formulation of medications are supporting the market growth. This is further influenced by the continuous conduction of clinical trials for new drug formation to overcome complications and the ineffectiveness of present drugs in the market. Moreover, the increasing consumer awareness regarding the benefits of cost-effective peptic ulcer drugs and their easy availability across multiple distribution channels is favoring the market growth. The advent of artificial intelligence (AI)-based pathology testing technology to perform diagnostic and forensic operations is also propelling the market growth. Other factors, such as extensive research and development (R&D) activities to enhance product efficacy and the increasing investments in the development of the over the counter (OTC) medications for treating peptic ulcers, are positively impacting the market growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each segment of the global peptic ulcer drugs market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on product type, ulcer type, and distribution channel.

Product Type Insights:

  • Proton Pump Inhibitors
  • Potassium-Competitive Acid Blocker (P-CAB)
  • Antacids
  • H2-Antagonists
  • Antibiotics
  • Ulcer protective
  • The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the product type. This includes proton pump inhibitors, potassium-competitive acid blocker (P-CAB), antacids, H2-antagonists, antibiotics, and ulcer protective. According to the report, antibiotics represented the largest segment.

Ulcer Type Insights:

  • Gastric Ulcer
  • Duodenal Ulcer
  • Others
  • A detailed breakup and analysis of the peptic ulcer drugs market based on the ulcer type has also been provided in the report. This includes gastric ulcer, duodenal ulcer, and others. According to the report, duodenal ulcer accounted for the largest market share.

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for peptic ulcer drugs. Some of the factors driving the North America peptic ulcer drugs market included the increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various peptic ulcer curing drugs over invasive surgeries and the fueling need for over-the-counter (OTC) medications in the healthcare sector.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global peptic ulcer drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novitium Pharma LLC, Pfizer Inc., PharmaKing Co. Ltd., RedHill Biopharma Ltd, Viatris Inc., Yuhan Corporation, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global peptic ulcer drugs market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global peptic ulcer drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive peptic ulcer drug markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the ulcer type?
  • What is the breakup of the market based on the distribution channel?
  • What is the competitive structure of the global peptic ulcer drugs market?
  • Who are the key players/companies in the global peptic ulcer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peptic Ulcer Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Potassium-Competitive Acid Blocker (P-CAB)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antacids
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 H2-Antagonists
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antibiotics
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Ulcer Protective
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Ulcer Type

  • 7.1 Gastric Ulcer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Duodenal Ulcer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boehringer Ingelheim International GmbH
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Novitium Pharma LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PharmaKing Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 RedHill Biopharma Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Viatris Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Yuhan Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zydus Lifesciences Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Peptic Ulcer Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Peptic Ulcer Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Peptic Ulcer Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Peptic Ulcer Drugs Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Peptic Ulcer Drugs Market: Breakup by Ulcer Type (in %), 2022
  • Figure 6: Global: Peptic Ulcer Drugs Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Peptic Ulcer Drugs Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Peptic Ulcer Drugs (Antacids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Peptic Ulcer Drugs (Antacids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Peptic Ulcer Drugs (H2-Antagonists) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Peptic Ulcer Drugs (H2-Antagonists) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Peptic Ulcer Drugs (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Peptic Ulcer Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Peptic Ulcer Drugs (Ulcer Protective) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Peptic Ulcer Drugs (Ulcer Protective) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Peptic Ulcer Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Peptic Ulcer Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Peptic Ulcer Drugs Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Peptic Ulcer Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Peptic Ulcer Drugs Industry: Value Chain Analysis
  • Figure 83: Global: Peptic Ulcer Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peptic Ulcer Drugs Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Ulcer Type (in Million US$), 2023-2028
  • Table 4: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Peptic Ulcer Drugs Market: Competitive Structure
  • Table 7: Global: Peptic Ulcer Drugs Market: Key Players